AzTrials
AzTrials

Spinal Cord InjuriesNCT03340792

Effects of Ambulation Training Utilizing an Exoskeleton Robot on Subjects With Spinal Cord Injury

A study testing Ambulation training utilizing an exoskeleton robot in people with Spinal Cord Injuries, run by China Medical University Hospital at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The present study aims to investigate the effects of ReWalk exoskeleton robot training on various physiological and psychological parameters among subjects with spinal cord injury, including body composition and bone mineral mass, balance ability, bowel and bladder symptoms, severity of pain, psychological well-being… Read more about this study

Who is it for?
Ages 20 to 65 years
Conditions the study is for
Spinal Cord Injuries
What is being tested?
Ambulation training utilizing an exoskeleton robot
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteTaiwan
Study dates
23 Nov 2017to 31 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Between the age of 20-65 years old;
  • Have paraplegia resulting from thoracic or lumbar spinal cord injury.
  • At least 6 months after onset of the spinal cord injury
  • Well motivated and willing to participate 40 hours of ReWalk ambulation training sessions.

Who cannot join

  • Have spinal cord injury neurologic level above T4
  • Height greater than 190 cm or lower than160 cm
  • Weight greater than 100 kg
  • Have osteoporosis (T-score < -2.5)
  • Deep vein thrombosis
  • Severe orthostatic hypotension precluding standing and walking training
Show all 12Show fewer
  • Pregnancy
  • Cognitive impairments that would impact on the safe participation in the study
  • Severe spasticity of lower limbs (Modified Ashworth Scale >3)
  • Contracture of the ankle, or a knee flexion contracture greater than 10 degrees
  • Musculoskeletal conditions that affected gait capacity
  • Co-existence of other neurological diseases

Trial locations and contacts

1 site in 1 country.

Taiwan1 site, 1 recruiting
  • China Medical University Hospial

    Taichung, 404

    Nai-Hsin Meng, M.D., 886-4-22052121 ext. 2381, nsmeng@ms13.hinet.net

    Nai-Hsin Meng, M.D.

    Recruiting

Other trials in Taiwan

About this study

Official title: Evaluation of the Physiological and Psychological Effects of Ambulation Training Utilizing an Exoskeleton Robot on Subjects With Spinal Cord Injury

The present study aims to investigate the effects of ReWalk exoskeleton robot training on various physiological and psychological parameters among subjects with spinal cord injury, including body composition and bone mineral mass, balance ability, bowel and bladder symptoms, severity of pain, psychological well-being, and quality of life. Ten patients with paraplegia caused by spinal cord injury will be recruited from the out-patient clinic of Department of Physical Medicine and Rehabilitation at the China Medical University hospital. All participants will undergo dual X-ray absorptiometry to evaluate the baseline bone mineral density. Eligible participants will then take ReWalk training sessions comprises of 3 x 1-hour sessions per week for 40 sessions. A comprehensive battery of outcome measures, including body composition and bone mineral mass, balance ability, bowel and bladder symptoms, severity of pain, psychological well-being, and quality of life, will be utilized for comparison after 40 sessions of ReWalk ambulation training.

Read the detailed description

The loss of upright mobility has a profound effect on the health and quality of life for individuals with a spinal cord injury (SCI). The ReWalk exoskeleton is an FDA-cleared, wearable, computer-controlled exoskeleton robot that enables subjects with SCI to stand and walk using crutches to keep balance. China Medical University Hospital is the second hospital in Taiwan to acquire this relatively new rehabilitation robot. ReWalk exoskeleton not only helps the patients with paraplegia regain their ability to walk, previous studies also suggest that restoration of upright mobility may help mitigate the physical and psychological decline routinely experienced by individuals with SCI.

The present study aims to investigate the effects of ReWalk exoskeleton robot training on various physiological and psychological parameters among subjects with spinal cord injury, including body composition and bone mineral mass, balance ability, bowel and bladder symptoms, severity of pain, psychological well-being, and quality of life. Ten patients with paraplegia caused by spinal cord injury will be recruited from the out-patient clinic of Department of Physical Medicine and Rehabilitation at the China Medical University hospital. All participants will undergo dual X-ray absorptiometry to evaluate the baseline bone mineral density. Eligible participants will then take ReWalk training sessions comprises of 3 x 1-hour sessions per week for 40 sessions. The first 20 or so hours of training sessions focus on basic ReWalk skills, and the following training sessions focus on advanced ReWalk skills. A comprehensive battery of outcome measures, including body composition and bone mineral mass, balance ability, bowel and bladder symptoms, severity of pain, psychological well-being, and quality of life, will be utilized to obtain an in-depth overview and comparison of the treatment efficacy after 40 sessions of ReWalk ambulation training. The measures include: muscle strength measurements, Berg Balance Scale, modified Functional Reach Test, 10-Meters Walking Test, Timed Up and Go test, the Short Form-36 and Spinal Cord Injury-Quality Of Life questionnaires for health-related quality of life measurement. Dual X-ray absorptiometry will be used to measure the bone mineral density of the lumbar spine, the proximal femoral region and the distal forearms. It will also be used to estimate fat mass and lean body mass of the participants. All the outcome assessments, except for the Timed Up and Go and the 10-Metersr Walking Test, will be performed prior to the first training session and again at the end of the ReWalk ambulation training sessions. Descriptive data will be provided for all demographic parameters and with a mix-design ANOVA analysis employed to compare pre- and post-training conditions for all repeated outcome measures.

Being tested
Ambulation training utilizing an exoskeleton robot
Keywords
Exoskeleton Device, Rehabilitation, Body composition, Quality of Life
Medical subject headings
Spinal Cord Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ambulation training utilizing an exoskeleton robotDevice

    Participants undergo 40 hours of ambulation training utilizing an exosksleton robot within 3 months.

Study groups in NCT03340792
Study groupRoleWhat they receive
Exoskeleton robot ambulation trainingExperimentalAmbulation training utilizing an exoskeleton robot
Receives: Device: Ambulation training utilizing an exoskeleton robot

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. bone mineral density

    bone mineral density of the lumbar spine, the proximal femoral region and the distal forearms, measured by dual X-ray absorptiometry

    Measured: Change from baseline at 1 week after completion of 40 hours of ambulation training

Secondary outcomes (5)
  1. SF-36

    SF-36 contains 36 items comprising eight subscales: physical functioning (PF), role limitations due to physical problems (RP), bodily pain, general health perceptions (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH). All subscales are transformed into a 0-100 scale, with 100 indicating the best status.

    Measured: change from baseline at 1 week after completion of 40 hours of ambulation training

  2. Spinal Cord Injury-Quality of Life measurement system

    The SCI-QOL consists of 19 item banks, including the SCI-Functional Index banks, and 3 fixed-length scales measuring physical, emotional, and social aspects of health-related QOL (HRQOL). A description of the score range (and which values are considered to be a better or worse outcome) is not included because it greatly exceeds the 999-character limitation allowed in the box of "descrpition"

    Emotional Health Domain:

    Positive Affect \& Well-Being, Depression, Anxiety, Stigma, Resilience, Grief/Loss, Self-Esteem and Psychological Trauma

    Physical-Medical Health Domain:

    Skin/Pressure Ulcers Scale, Bladder Complications Scale, Bladder Management Difficulties, Bowel Management Difficulties, Pain Interference and Pain Behavior Scale.

    Social Participation Domain:

    Ability to Participate in Social Roles and Activities, Satisfaction with Social Roles and Activities, Independence.

    SCI-Functional Index banks: Basic Mobility, Ambulation, Fine Motor, Self-Care and Wheelchair activities.

    Measured: change from baseline at 1 week after completion of 40 hours of ambulation training

  3. fat mass

    fat mass measured by dual X-ray absorptiometry

    Measured: change from baseline at 1 week after completion of ambulation training

  4. lean body mass

    lean body mass measured by dual X-ray absorptiometry

    Measured: change from baseline at 1 week after completion of 40 hours of ambulation training

  5. Berg Balance Scale

    measuring sitting balance ability; minimum score: 0, maximu score 56; higher values represent a better outcome

    Measured: change from baseline at 1 week after completion of 40 hours of ambulation training

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2017
  2. Study start23 Nov 2017
  3. Primary completion31 Oct 2019 (estimated)
  4. Study completion31 Dec 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
10 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03340792
Sponsor's protocol ID
DMR-107-085
Status last verified
Jan 2018
First submitted
7 Nov 2017
Last updated
8 Jan 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Ambulation training utilizing an exoskeleton robot in people with Spinal Cord Injuries, run by China Medical University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Nai-Hsin Meng, M.D. (886-4-22052121 ext. 2381, nsmeng@ms13.hinet.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

bone mineral density (time frame: Change from baseline at 1 week after completion of 40 hours of ambulation training). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jan 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT03340792 | AzTrials